Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jozef Malysz

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Children (Basel, Switzerland)|February 25, 2022
Chronic Generalized Lymphadenopathy in a Child-Progressive Transformation of Germinal Centers (PTGC)Carson Wills, Katherine Mercer, Jozef Malysz, et al.
Rare Tumors|October 23, 2012
Clinical features and outcomes of plasma cell leukemia: a single-institution experience in the era of novel agentsGiampaolo Talamo, Nathan G Dolloff, Kamal Sharma, et al.
Ear, Nose, & Throat Journal|December 14, 2017
Myeloid sarcoma of the thyroidDana Goldenberg, Monika Joshi, Jozef Malysz, et al.
Cancer Genetics|June 19, 2022
Mast cell leukemia with novel BRAF variant and concomitant atypical KIT variantTiane Chen, Jozef Malysz, Erik Washburn, et al.
Journal of Visualized Experiments : Jove|February 26, 2019
An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell ArteritisShirley Albano-Aluquin, Jozef Malysz, Michal Kidacki, et al.
American Journal of Clinical and Experimental Immunology|January 20, 2018
An immunohistochemical analysis of folate receptor beta expression and distribution in giant cell arteritis - a pilot studyShirley Albano-Aluquin, Jozef Malysz, Vincent R Aluquin, et al.
American Journal of Hematology|September 17, 2011
Basophils and plasmacytoid dendritic cells are potential sources for error in flow cytometric monitoring of patients receiving anti-CD22 therapies. AKA not all anti-CD22 antibodies are created equalMalcolm Acon-Laws, Michael G Bayerl, Christopher Ehman, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 14, 2016
Clinical Implications of CD30 Expression in Aggressive B-Cell LymphomasJozef Malysz, Patrick Erdman, Jeremy Klapper, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 20, 2014
Report of 6 cases of large granular lymphocytic leukemia and plasma cell dyscrasiaJihua Cheng, Giampaolo Talamo, Jozef Malysz, et al.
Circulation. Cardiovascular Interventions|December 18, 2014
Cardiac paragangliomaPradeep K Yadav, Giselle A Baquero, Jozef Malysz, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Children (Basel, Switzerland)|February 25, 2022
Chronic Generalized Lymphadenopathy in a Child-Progressive Transformation of Germinal Centers (PTGC)Carson Wills, Katherine Mercer, Jozef Malysz, et al.
Rare Tumors|October 23, 2012
Clinical features and outcomes of plasma cell leukemia: a single-institution experience in the era of novel agentsGiampaolo Talamo, Nathan G Dolloff, Kamal Sharma, et al.
Ear, Nose, & Throat Journal|December 14, 2017
Myeloid sarcoma of the thyroidDana Goldenberg, Monika Joshi, Jozef Malysz, et al.
Cancer Genetics|June 19, 2022
Mast cell leukemia with novel BRAF variant and concomitant atypical KIT variantTiane Chen, Jozef Malysz, Erik Washburn, et al.
Journal of Visualized Experiments : Jove|February 26, 2019
An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell ArteritisShirley Albano-Aluquin, Jozef Malysz, Michal Kidacki, et al.
American Journal of Clinical and Experimental Immunology|January 20, 2018
An immunohistochemical analysis of folate receptor beta expression and distribution in giant cell arteritis - a pilot studyShirley Albano-Aluquin, Jozef Malysz, Vincent R Aluquin, et al.
American Journal of Hematology|September 17, 2011
Basophils and plasmacytoid dendritic cells are potential sources for error in flow cytometric monitoring of patients receiving anti-CD22 therapies. AKA not all anti-CD22 antibodies are created equalMalcolm Acon-Laws, Michael G Bayerl, Christopher Ehman, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 14, 2016
Clinical Implications of CD30 Expression in Aggressive B-Cell LymphomasJozef Malysz, Patrick Erdman, Jeremy Klapper, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 20, 2014
Report of 6 cases of large granular lymphocytic leukemia and plasma cell dyscrasiaJihua Cheng, Giampaolo Talamo, Jozef Malysz, et al.
Circulation. Cardiovascular Interventions|December 18, 2014
Cardiac paragangliomaPradeep K Yadav, Giselle A Baquero, Jozef Malysz, et al.
Pageof 4